This inventor holds 1 USPTO granted patent. Top assignee: Apotex Technologies Inc.. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Blaise N′Zemba: Innovator in Pharmaceutical Crystallization
Introduction
Blaise N′Zemba, based in Brampton, Canada, is an accomplished inventor renowned for his contributions in the field of pharmaceuticals. His innovative work focuses on the development of crystalline forms, which plays a significant role in enhancing drug efficacy and stability.
Latest Patents
Blaise holds a patent for "Crystalline forms of the mono-sodium salt of D-isoglutamyl-D-tryptophan." This invention pertains to the pharmaceutical compositions that include these crystalline forms and their applications in treating various diseases and conditions. Notably, it details the pivotal crystal modification 1 (polymorphic form F) of the mono-sodium salt, showcasing his dedication to advancing pharmaceutical science.
Career Highlights
Blaise N′Zemba is currently affiliated with Apotex Technologies Inc., a leading player in the pharmaceutical industry. His role has allowed him to explore and contribute to innovative solutions aimed at improving medication formulations. The impact of his work can significantly influence patient health outcomes and therapeutic effectiveness.
Collaborations
Throughout his career, Blaise has worked alongside notable professionals including Tim Fat Tam and Regis C Leung-Toung. Their collaborative efforts have fostered a productive environment that encourages the exchange of ideas and advances in research, particularly in crystalline pharmaceutical compositions.
Conclusion
Blaise N′Zemba exemplifies the spirit of innovation in the pharmaceutical sector. His patent on the crystalline forms of D-isoglutamyl-D-tryptophan not only highlights his inventive capabilities but also his commitment to improving healthcare solutions. As he continues his journey at Apotex Technologies Inc., the potential for future breakthroughs remains promising.